Does ROFLUMILAST Cause Therapeutic product effect incomplete? 106 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 106 reports of Therapeutic product effect incomplete have been filed in association with ROFLUMILAST (ROFLUMILAST). This represents 3.9% of all adverse event reports for ROFLUMILAST.
106
Reports of Therapeutic product effect incomplete with ROFLUMILAST
3.9%
of all ROFLUMILAST reports
0
Deaths
37
Hospitalizations
How Dangerous Is Therapeutic product effect incomplete From ROFLUMILAST?
Of the 106 reports, 37 (34.9%) required hospitalization.
Is Therapeutic product effect incomplete Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROFLUMILAST. However, 106 reports have been filed with the FAERS database.
What Other Side Effects Does ROFLUMILAST Cause?
Death (569)
Dyspnoea (433)
Chronic obstructive pulmonary disease (292)
Diarrhoea (265)
Off label use (242)
Weight decreased (224)
Nausea (191)
Pneumonia (176)
Headache (166)
Malaise (164)
What Other Drugs Cause Therapeutic product effect incomplete?
ALBUTEROL (8,496)
ADALIMUMAB (6,986)
PREDNISONE (6,709)
METHOTREXATE (6,037)
TOFACITINIB (4,914)
SECUKINUMAB (4,661)
BUDESONIDE\FORMOTEROL (4,392)
TIOTROPIUM (4,327)
MEPOLIZUMAB (4,106)
ETANERCEPT (3,961)
Which ROFLUMILAST Alternatives Have Lower Therapeutic product effect incomplete Risk?
ROFLUMILAST vs ROLAPITANT
ROFLUMILAST vs ROMIDEPSIN
ROFLUMILAST vs ROMIPLOSTIM
ROFLUMILAST vs ROMOSOZUMAB
ROFLUMILAST vs ROMOSOZUMAB-AQQG